As nirsevimab is the first product of its kind, there are many things to consider during the first season of implementation. Below are various resources to support implementation in both inpatient and outpatient settings.  

Ambulatory/Outpatient Practice Resources 

General Resources 

Last Updated

10/06/2023

Source

American Academy of Pediatrics